You might also like
The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
Validating herbal, natural products and drug candidates in cancer patient cells to design optimal clinical trials.
1st Floor, AIMSR Building,
Apollo Health City,
Hyderabad 500 096